Logo image of AZRN.AS

AZERION GROUP N.V. (AZRN.AS) Stock Fundamental Analysis

AMS:AZRN - Euronext Amsterdam - NL00150006Z9 - Common Stock - Currency: EUR

1.22  -0.03 (-2.01%)

Fundamental Rating

1

AZRN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 20 industry peers in the Interactive Media & Services industry. AZRN has a bad profitability rating. Also its financial health evaluation is rather negative. AZRN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AZRN had negative earnings in the past year.
In the past year AZRN has reported a negative cash flow from operations.
AZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFAZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

AZRN's Return On Assets of -8.58% is on the low side compared to the rest of the industry. AZRN is outperformed by 65.00% of its industry peers.
AZRN has a Return On Equity of -153.55%. This is in the lower half of the industry: AZRN underperforms 70.00% of its industry peers.
Industry RankSector Rank
ROA -8.58%
ROE -153.55%
ROIC N/A
ROA(3y)-8.64%
ROA(5y)N/A
ROE(3y)-78.44%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AZRN.AS Yearly ROA, ROE, ROICAZRN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 100 -100

1.3 Margins

AZRN has a worse Gross Margin (31.92%) than 80.00% of its industry peers.
The Profit Margin and Operating Margin are not available for AZRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AZRN.AS Yearly Profit, Operating, Gross MarginsAZRN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20

More info and screens

0

2. Health

2.1 Basic Checks

AZRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AZRN has been increased compared to 1 year ago.
The debt/assets ratio for AZRN is higher compared to a year ago.
AZRN.AS Yearly Shares OutstandingAZRN.AS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
AZRN.AS Yearly Total Debt VS Total AssetsAZRN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.54, we must say that AZRN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AZRN (0.54) is worse than 65.00% of its industry peers.
A Debt/Equity ratio of 7.33 is on the high side and indicates that AZRN has dependencies on debt financing.
The Debt to Equity ratio of AZRN (7.33) is worse than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.33
Debt/FCF N/A
Altman-Z 0.54
ROIC/WACCN/A
WACC10.76%
AZRN.AS Yearly LT Debt VS Equity VS FCFAZRN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 0.80 indicates that AZRN may have some problems paying its short term obligations.
AZRN has a worse Current ratio (0.80) than 70.00% of its industry peers.
A Quick Ratio of 0.80 indicates that AZRN may have some problems paying its short term obligations.
AZRN's Quick ratio of 0.80 is on the low side compared to the rest of the industry. AZRN is outperformed by 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
AZRN.AS Yearly Current Assets VS Current LiabilitesAZRN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for AZRN have decreased strongly by -384.65% in the last year.
Looking at the last year, AZRN shows a small growth in Revenue. The Revenue has grown by 7.18% in the last year.
EPS 1Y (TTM)-384.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.09%
Revenue 1Y (TTM)7.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.93%

3.2 Future

The Earnings Per Share is expected to grow by 67.33% on average over the next years. This is a very strong growth
Based on estimates for the next years, AZRN will show a quite strong growth in Revenue. The Revenue will grow by 8.50% on average per year.
EPS Next Y80%
EPS Next 2Y67.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.04%
Revenue Next 2Y9.29%
Revenue Next 3Y8.5%
Revenue Next 5YN/A

3.3 Evolution

AZRN.AS Yearly Revenue VS EstimatesAZRN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 200M 400M 600M
AZRN.AS Yearly EPS VS EstimatesAZRN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.05 -0.05 0.1 -0.1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

AZRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 14.95, the valuation of AZRN can be described as correct.
Based on the Price/Forward Earnings ratio, AZRN is valued cheaper than 90.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.19. AZRN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 14.95
AZRN.AS Price Earnings VS Forward Price EarningsAZRN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

75.00% of the companies in the same industry are more expensive than AZRN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.83
AZRN.AS Per share dataAZRN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AZRN's earnings are expected to grow with 67.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.33%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AZRN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AZERION GROUP N.V.

AMS:AZRN (6/19/2025, 7:00:00 PM)

1.22

-0.03 (-2.01%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)05-28 2025-05-28
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners45.38%
Ins Owner ChangeN/A
Market Cap149.90M
Analysts82.86
Price Target2.04 (67.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-31.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.95
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B 4.1
P/tB N/A
EV/EBITDA 13.83
EPS(TTM)-0.47
EYN/A
EPS(NY)0.08
Fwd EY6.69%
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS4.55
BVpS0.3
TBVpS-2.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.58%
ROE -153.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.92%
FCFM N/A
ROA(3y)-8.64%
ROA(5y)N/A
ROE(3y)-78.44%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 7.33
Debt/FCF N/A
Debt/EBITDA 10.04
Cap/Depr 39.76%
Cap/Sales 3.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z 0.54
F-Score3
WACC10.76%
ROIC/WACCN/A
Cap/Depr(3y)51.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.46%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-384.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.09%
EPS Next Y80%
EPS Next 2Y67.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.93%
Revenue Next Year10.04%
Revenue Next 2Y9.29%
Revenue Next 3Y8.5%
Revenue Next 5YN/A
EBIT growth 1Y-132.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55%
EBIT Next 3Y27.65%
EBIT Next 5YN/A
FCF growth 1Y-151.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.37%
OCF growth 3YN/A
OCF growth 5YN/A